Swedbank AB Raises Stock Position in Corteva, Inc. $CTVA

Swedbank AB lifted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 142.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,898,735 shares of the company’s stock after buying an additional 1,117,021 shares during the period. Swedbank AB’s holdings in Corteva were worth $127,272,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Activest Wealth Management lifted its stake in shares of Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the third quarter valued at about $25,000. Redmont Wealth Advisors LLC purchased a new stake in shares of Corteva during the 3rd quarter valued at about $29,000. Jackson Grant Investment Advisers Inc. raised its holdings in shares of Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after buying an additional 213 shares during the period. Finally, KERR FINANCIAL PLANNING Corp acquired a new position in Corteva during the 3rd quarter worth approximately $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Price Performance

CTVA stock opened at $81.99 on Thursday. The stock’s 50 day moving average is $80.66 and its two-hundred day moving average is $72.48. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The company has a market capitalization of $55.04 billion, a PE ratio of 48.23, a P/E/G ratio of 2.88 and a beta of 0.59. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.88% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the business posted $1.13 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 3.62 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is 45.57%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several recent research reports. Jefferies Financial Group increased their price objective on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Berenberg Bank upped their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. Wolfe Research raised their price target on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, Rothschild & Co Redburn boosted their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average target price of $86.38.

Insiders Place Their Bets

In other news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.15% of the stock is currently owned by corporate insiders.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Q1 beat — Corteva reported $1.50 EPS vs. ~$1.18 consensus and revenue of $4.91B (up ~11% YoY), driven by stronger sales across its Seed and Crop Protection portfolios. This was the main catalyst for initial bullishness after the print. Corteva, Inc. (CTVA) Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Business momentum — Management highlighted continued strength in Seed and Crop Protection technologies and progress on growth platforms, plus productivity/cost initiatives that are improving the company’s financial profile. This supports medium‑term margin and cash‑flow improvement expectations. Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
• Positive Sentiment: Planned separation on track — Management reiterated that the planned separation (targeted for 4Q 2026) remains on schedule; investors often view an on‑track separation as potential value unlocking. Corteva Agriscience: Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
• Neutral Sentiment: Guidance reaffirmed — The company reaffirmed FY‑2026 EPS guidance at $3.450–3.700, signaling management sees the beat as consistent with earlier expectations; that removes downside surprise risk but does not materially raise the bar. Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
• Neutral Sentiment: Call color — Transcripts show management focused on execution, margin expansion and separation planning; there were no major changes to capital allocation or a materially raised FY outlook on the call. Read the full call transcript for management tone and Q&A. Corteva, Inc. (CTVA) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Guidance vs. street — The reaffirmed FY range’s midpoint sits slightly below some street expectations (consensus ~3.65), so while management didn’t cut guidance, the lack of an upward revision likely disappointed some investors and pressured the stock. Compared to Estimates, Corteva, Inc. (CTVA) Q1 Earnings: A Look at Key Metrics
• Negative Sentiment: Profit‑taking / valuation — After a solid quarter and a run toward the 12‑month high, the stock is pulling back as investors lock in gains; valuation metrics (e.g., a relatively high P/E) may amplify the downside on a cautious guidance reaction. Corteva (CTVA) Q1 2026 Earnings Transcript

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.